martes, 30 de junio de 2026
Overview of President Trump’s Executive Actions Impacting LGBTQ+ Health Authors: Lindsey Dawson and Jennifer Kates Published: Jun 29, 2026
https://www.kff.org/lgbtq/overview-of-president-trumps-executive-actions-impacting-lgbtq-health/
This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LGBTQ+ people’s health. It lists the action taken by date, provisions relevant to LGBTQ+ health, and describes potential impact, including litigation challenging these actions.
KFF Tracker: America First MOU Bilateral Global Health Agreements Published: Jun 29, 2026
https://www.kff.org/global-health-policy/kff-tracker-america-first-mou-bilateral-global-health-agreements/
On September 18, 2025, the U.S. government (USG) released its new America First Global Health Strategy, which details how the U.S. will engage in global health efforts moving forward. As part of this new strategy, the U.S. has announced that it will be establishing bilateral health cooperation agreements with countries that receive U.S. global health assistance. These agreements, or Memorandums of Understanding (MOUs), between the U.S. and partner countries represent five-year plans (for the period 2026-2030) outlining U.S. engagement in each country’s health efforts with the goal of “helping countries move toward more resilient and durable health systems.” Central to these plans is transitioning country programs from U.S. assistance to long-term country ownership, with a pledge from each partner country to increase its domestic health spending, or co-investment in health, over the next five years as the U.S. decreases its health assistance. The U.S. began signing these agreements in late 2025 and this process is ongoing. Implementation is slated for later this year.
Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge Authors: Juliette Cubanski and Nolan Sroczynski Published: Jun 29, 2026Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge Authors: Juliette Cubanski and Nolan Sroczynski Published: Jun 29, 2026
https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare. The program, known as the Medicare GLP-1 Bridge, provides coverage of GLP-1s used for weight reduction and weight management to eligible beneficiaries enrolled in Medicare Part D, although the program will operate outside of the Part D benefit and payment system. Under the Medicare GLP-1 Bridge, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 monthly copayment, which will not count towards the Part D deductible or out-of-pocket spending cap and Part D Low-Income Subsidy cost-sharing assistance will not apply. The temporary program, running from July 2026 through December 2027, does not change the current statutory prohibition on Medicare coverage of drugs used for weight loss but instead is being established using the federal government’s Section 402 demonstration authority.
Tennessee Plans to Share Data on Children with Disabilities with Immigration Authorities Authors: Drishti Pillai, Akash Pillai, and Samantha Artiga Published: Jun 29, 2026
https://www.kff.org/immigrant-health/tennessee-plans-to-share-data-on-children-with-disabilities-with-immigration-authorities/
According to recent news reports, the families of about 400 children with disabilities who are enrolled in Tennessee’s Children’s Special Services (CSS) program received notices from the state health department in early June stating that if their child continued to remain enrolled in CSS beyond June 30, 2026, their information would be reported to a central state immigration enforcement agency. However, following a lawsuit filed by physicians in the state, a judge issued a temporary restraining order on June 24, 2026, to prevent this data sharing from taking place. Tennessee is one of at least six states that have taken actions as of June 2026 to require state agencies to report applicants or recipients of Medicaid and/or other public benefits whose immigration status could not be verified and/or who were verified to not have lawful presence with immigration enforcement authorities. Under longstanding federal law, Medicaid and other federally funded health coverage are already limited to lawfully present immigrants.
Nearly Four Million Medicare Beneficiaries Could Be Eligible for the Temporary Medicare GLP-1 Bridge Program Covering These Drugs for Weight Loss Published: Jun 29, 2026
https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-could-be-eligible-for-the-temporary-medicare-glp-1-bridge-program-covering-these-drugs-for-weight-loss/
A new KFF analysis finds that 3.8 million Medicare beneficiaries met the criteria to be eligible for the new Medicare GLP-1 Bridge, based on claims data from 2023.
AI: Show Me the Outcomes June 30, 2026
https://www.kff.org/other-health/ai-show-me-the-outcomes/
Episode 10, AI Series: Chip talks with Dr. Toyin Ajayi, co-founder and CEO of Cityblock Health, which delivers value-based care to more than 100,000 Medicaid and dual-eligible members across ten states, many of them people of color managing chronic conditions. [AB1.1][AB1.2][MR1.3][AB1.4]Ajayi makes a pointed case: Roughly 60 percent of health care AI investment goes to billing, coding, and risk adjustment — making sure someone gets paid — while only a fraction goes to delivering care. If we continue to concentrate AI there, she warns, it will drive up cost without improving outcomes. She says there is a better way — AI built for care can lower costs by improving care for those hardest to reach. She and Chip discuss what that looks like and how Cityblock is using AI now to improve care and the patient experience for its members.
Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information While More People Identify Vaccine Myths as “Definitely False” than “Definitely True,” At Least Half Are Uncertain About What to Believe Published: Jun 30, 2026
Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information
While More People Identify Vaccine Myths as “Definitely False” than “Definitely True,” At Least Half Are Uncertain About What to Believe
Published: Jun 30, 2026
https://www.kff.org/health-information-trust/poll-people-without-a-trusted-health-care-provider-are-more-likely-to-endorse-vaccine-myths-as-are-those-who-often-use-social-media-or-ai-for-health-information/
People who don’t have a trusted health care provider are more likely than people with one to believe or lean toward believing several common myths about vaccines, a new KFF Tracking Poll on Health Information and Trust reveals. Similarly, people who use social media or artificial intelligence (AI) chatbots at least weekly for health information are more likely than those who don’t to endorse these false vaccine claims.
Untold KFF History Volume 1: South Africa Author: Drew Altman Published: Jun 25, 2026
https://www.kff.org/from-drew-altman/untold-kff-history-volume-1-south-africa/
Everyone who knows KFF today thinks of us as the independent source of health policy analysis, polling, and in-depth news coverage. As we head to a leadership transition next year from me to Larry Levitt and Molly Brodie, I plan to write about some of the other things we have done over the years that are part of our history and the soul of the organization, but may not be remembered by our current audiences. Our decades long commitment to South Africa is the place to start.
KFF Tracking Poll on Health Information and Trust: Update on Common Vaccine Myths Authors: Alex Montero, Grace Sparks, Julian Montalvo III, Ashley Kirzinger, and Liz Hamel Published: Jun 30, 2026
https://www.kff.org/public-opinion/kff-tracking-poll-on-health-information-and-trust-update-on-common-vaccine-myths/?utm_campaign=22234741-KFF-Information-Trust&utm_medium=email&_hsenc=p2ANqtz-_keEbuJYGyAuTtK4m85Wcdny5RA5I__4noJRCgyZxU-ZumjYpt78g5vLqiARrimpSOMBuFeDv4xlh3sdouCwVJh8ZREQ&_hsmi=426231376&utm_content=426231376&utm_source=hs_email
Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information
While More People Identify Vaccine Myths as “Definitely False” than “Definitely True,” At Least Half Are Uncertain About What to Believe
People who don’t have a trusted health care provider are more likely than people with one to believe or lean toward believing several common myths about vaccines, a new KFF Tracking Poll on Health Information and Trust reveals. Similarly, people who use social media or artificial intelligence (AI) chatbots at least weekly for health information are more likely than those who don’t to endorse these false vaccine claims.
One example: Among adults who say they do not have a doctor or other health provider they trust to answer questions about their health, about 4 in 10 (39%) incorrectly believe that it is either “definitely” or “probably true” that MMR vaccines have been proven to cause autism in children, compared to a quarter (24%) among those who say they have a trusted provider.
Similarly, more than a third of people who report using social media (37%) or AI chatbots (35%) at least weekly for health information incorrectly say this myth is true, about twice the share among those who never use social media (16%) or AI (20%) for health information.
The poll finds a similar pattern for most of the other vaccine myths tested for people without a trusted doctor as well as for people who frequently use social media or AI for health information. The differences remain significant even when controlling for other factors such as age, race and ethnicity, education, partisanship, and insurance status.
Exposure to each of these false claims has been fairly steady in KFF polls over the past several years, though the share who report hearing the myth that mRNA vaccines can alter a person’s DNA dropped by 9 percentage points since April 2025 (from 45% to 36%). Exposure to the myth that measles vaccines are more dangerous than measles rose between 2024 and 2025, but has remained steady since then (29% now).
Across the four false vaccines claims, far more people say the claims are “definitely false” than say they are “definitely true,” but at least half of the public is less certain what to believe, falling into the malleable middle and saying each of these claims are either “probably true” or “probably false.”
While many parents who skip or delay recommended vaccines for their children express uncertainty over vaccine myths, they are also about twice as likely as parents who keep their children up to date on vaccines to believe or lean toward believing false claims about the measles and COVID-19 vaccines.
The pattern is true for each of the four false claims: that MMR vaccines cause autism in children (57% among those who delay or skip vaccines v. 30% among those who stay up to date), that more people died from COVID-19 vaccines than the virus itself (55% v. 29%), that mRNA vaccines alter DNA (52% v. 23%), and that measles vaccines are more dangerous than measles (43% v. 18%). This relationship remains significant even when controlling for factors like age, education, and partisanship.
The poll also includes a new analysis that identifies patterns of belief across the four false claims and sorts them into a new belief typology. A small share (8%) are consistent or leaned myth believers (saying all four claims are either “probably” or “definitely true”) and just over half (55%) are consistent or leaned myth deniers (saying all four claims are either “probably” or “definitely false”). About 3 in 10 (31%) are in the mixed middle, providing a range of true and false answers and lacking certainty on at least half of the claims.
Designed and analyzed by public opinion researchers at KFF, this survey was conducted May 7-31, 2026, online and by telephone among a nationally representative sample of 2,480 U.S. adults in English and in Spanish. The margin of sampling error is plus or minus three percentage points for the full sample. For results based on other subgroups, the margin of sampling error may be higher.
lunes, 29 de junio de 2026
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists Tamsin Paternoster | Euronews | June 29, 2026
https://geneticliteracyproject.org/2026/06/29/europes-heat-wave-fueled-recycled-climate-denial-narratives-and-harassment-of-climate-scientists/
A May heatwave across Europe has shattered temperature records and sparked a wave of familiar claims online that attempt to throw climate science into disrepute.
One post on X, viewed thousands of times, claims that historic heatwaves, such as those in London in the summer of 1976 and in 1921, prove that the current high temperatures are nothing unusual.
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin Christina Jewett, Kenneth Vogel | New York Times | June 29, 2026
https://geneticliteracyproject.org/2026/06/29/how-the-dubious-trump-backed-addictive-drug-kratom-could-enrich-cabinet-secretary-markwayne-mullin/
Sold in gas stations across America, kratom has been linked to liver toxicity, seizures and thousands of deaths.
Powerful figures close to President Trump, including Homeland Security Secretary Markwayne Mullin, pushed to downplay those concerns.
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money Jess Steier | Unbiased Science | June 29, 2026
https://geneticliteracyproject.org/2026/06/29/viewpoint-the-facts-behind-the-grifter-promoting-wellness-and-anti-aging-peptide-craze-dont-waste-your-money/
The wellness craze of the moment. Peptides themselves are just short chains of amino acids, the same building blocks that make up proteins, and the science on how they work is well established. The problem is a distinction the industry is counting on you missing, which is what Part one of our ongoing peptide series digs into. The FDA-approved peptide drugs like insulin and GLP-1s, backed by decades of trials, are not the same thing as the unregulated wellness peptides (BPC-157, TB-500, and friends) sold for recovery and anti-aging. Most of those have little or no human data, some were built as research tools and never meant for people at all, and stacking several at once just multiplies the unknowns.
America’s trust in Trump-Kennedy’s CDC health recommendations is plunging Mary Van Beusekom
https://geneticliteracyproject.org/2026/06/26/americas-trust-in-trump-kennedys-cdc-health-recommendations-is-plunging/
More than a year into President Donald Trump’s second term, poll findings released on [June 9, 2026] showed that trust in federal public health agencies has nosedived, with half of US adults skeptical of recommendations from the Centers for Disease Control and Prevention (CDC), but most Americans are supportive of childhood vaccines.
The poll also found that, while over half of responde...
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science Giovanni Molteni Tagliabue | June 29, 2026
https://geneticliteracyproject.org/2026/06/29/viewpoint-the-dangerous-influence-of-woke-post-modernism-in-science/
From an article in Science magazine by journalist Rachael Zamzow, we learn that many social scientists believe that a published paper should include in its author details a “’positionality statement’ from each author describing how their identity might influence their work”, declaring “for example, race, ethnicity, geographic location, sexual orientation, gender identity, disability status, and career level”. Defending such a practice, one author maintains that it is “an invitation to think more broadly about what your role as a researcher is”. To illustrate the supposed benefits from such declarations, an imaginary case is offered: “If you’re an astronomer, for example, think about where your telescope is, she says. ‘Are you part of that community? Is that telescope put there with knowledge of the people who call that place their land?’”
Rural Minnesota City Fights Back Against Hospital's 'Decline' After 2009 Takeover
Rural Minnesota City Fights Back Against Hospital's 'Decline' After 2009 Takeover
The city of Fosston alleges that Essentia Health has failed to meet the community’s needs in violation of its affiliation agreement, MPR News reported. A ruling last week will allow Fosston to take its fight to terminate the local hospital’s affiliation agreement with Essentia to arbitration. One public health expert said the results of the case could have larger implications on the healthcare industry.
https://kffhealthnews.org/morning-breakout/health-industry-062926/
Shingles Vaccine May Help Protect Against Dementia
Shingles Vaccine May Help Protect Against Dementia
Experts think the reduction in brain inflammation, caused by the reactivation of the varicella-zoster virus in the body, might help protect against dementia. Patients in nursing facilities showed a 5.8% lower risk of developing dementia over the next four years after receiving at least one shot of the shingles vaccine, NBC News reports.
https://kffhealthnews.org/morning-breakout/pharmaceuticals-062926/
Dangerous Heat Wave This Week Will Leave Millions Sweltering
Dangerous Heat Wave This Week Will Leave Millions Sweltering
The eastern half of the U.S. is preparing to face likely record-breaking heat this week. Many areas will grapple with dangerous temps at or above 100 degrees. Meanwhile, a historic European heat wave has killed thousands in France.
https://kffhealthnews.org/morning-breakout/climate-and-health-062926/
Rapidly Spreading Ebola Outbreak In Congo Triggers Highest-Level US Response
Rapidly Spreading Ebola Outbreak In Congo Triggers Highest-Level US Response
The CDC has made the Ebola response a top priority, allowing the agency to swiftly dispatch staffing to the region. But some health service workers are expressing concerns that the hastily conducted training session has left some unprepared to handle an outbreak of this magnitude, Bloomberg reports.
https://kffhealthnews.org/morning-breakout/outbreaks-and-health-threats-062926/
Court Blocks Trump Administration's Effort To Weaken Air Quality Standards
Court Blocks Trump Administration's Effort To Weaken Air Quality Standards
The EPA had sought to scrap the National Ambient Air Quality Standards, which lowered the annual limit for small particulates known to cause adverse health effects when ingested or inhaled. Now, local and state officials must make plans to reduce soot pollution. Plus, in a new twist in the war on drugs, New Mexico is investigating a report that the DEA allowed fentanyl shipments to enter the U.S.
https://kffhealthnews.org/morning-breakout/administration-news-062926/
With Costs Surging And Subsidies Gone, Millions Drop Obamacare Plans
With Costs Surging And Subsidies Gone, Millions Drop Obamacare Plans
AP reports on federal data showing that roughly 3 million fewer Americans had Affordable Care Act health insurance plans in February compared with the same time last year, representing a 13% drop. Also in the news: ERs that can turn patients away, Medicare's obesity drug coverage, and more.
https://kffhealthnews.org/morning-breakout/healthcare-costs-062926/
Millions drop Obamacare health coverage after subsidies expire and costs rise By ALI SWENSON Updated 2:51 PM GMT-3, June 27, 2026
https://apnews.com/article/affordable-care-act-obamacare-health-subsidies-premiums-3dc9a0cd249a7622ce31e8559bfff729?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8xZnxqoLTr7OXAtJLuyUFid6yGjeWiWFvMf8PaYceqs8FxDj0VXg2vuzZwZIM0avdoiYqB3HpTKBSzYwEG7SXb-Cp4jg&_hsmi=426021881&utm_content=426021881&utm_source=hs_email
AP: Millions Drop Obamacare Health Plans After Subsidies Expire And Costs Rise
About 3 million fewer people in the United States had Affordable Care Act health insurance plans in February compared with the same time last year, according to new federal data. In the report released Friday, the U.S. Department of Health and Human Services suggested the 13% drop in enrollment from 22.1 million people in 2025 to 19.2 million this year could be attributed to a federal crackdown on fraudulent or “phantom” enrollment. But health analysts said it was more likely related to the Jan. 1 expiration of federal subsidies, which caused a surge in plan costs that resulted in many people being unable to pay their premiums. (Swenson, 6/27)
Reporters Talk Through FDA Sunscreen Move and Closure of Rural Dialysis Clinics June 27, 2026
https://kffhealthnews.org/on-air/on-air-june-27-2026-fda-sunscreen-ingredient-filter-nebraska-rural-dialysis-clinics/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_iBwRK_BGeuVjT2IVRxwvZKLuvWX0KyVXFo8dINfVTg8aeyM3SxVwCLTD2obRDLpa2IL9q9DWn16NYR8z8FVfXj9cmAA&_hsmi=426021881&utm_content=426021881&utm_source=hs_email
KFF Health News: Reporters Talk Through FDA Sunscreen Move And Closure Of Rural Dialysis Clinics
KFF Health News freelance contributor Michael Scaturro discussed the FDA’s new approval of a sunscreen chemical on Science Friday on June 19. (6/27)
She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help By Samantha Liss June 29, 2026
https://kffhealthnews.org/health-care-costs/prior-authorization-medicare-advantage-humana-missouri-bill-of-the-month-june-2026/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9j93nSgxJ0yGUHj7-T4DOxQ7yvppQMk6fjve2hKbj58UVZYMfkQe1_F2Nen5u1DweCh82H45Z64DGz2iNw919FOLPfyg&_hsmi=426021881&utm_content=426021881&utm_source=hs_email
KFF Health News: She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
Over four consecutive days in January, Margaret Hvatum ran a 5K, a 10K, a half-marathon, and a full marathon. The 70-year-old covered a combined distance that’s nearly equivalent to running the length of Manhattan four times. By the end of the month, she was in a hospital bed. Hvatum, a part-time computer science professor, has a weakened immune system due to a rare condition known as primary immunodeficiency, which makes it difficult for her body to fight infections. Prior to her 2005 diagnosis, she had four bouts of shingles, a painful rash caused by a virus. (Liss, 6/29)
Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured By Daniel Chang, Fred Clasen-Kelly, and Olga Pierce, The Trace June 29, 2026
Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
A data analysis by KFF Health News and The Trace offers a look at how insurance affects the care of gunshot wound victims.
By Daniel Chang, Fred Clasen-Kelly, and Olga Pierce, The Trace June 29, 2026
https://kffhealthnews.org/public-health/florida-hospitals-guns-gunshot-firearm-wounds-uninsured-discharge-data-analysis/
KFF Health News: Florida Hospitals Act Fast To Discharge Gun Victims — Especially If They’re Not Insured
Alea Bates wasn’t ready to leave Tallahassee Memorial HealthCare’s main hospital four days after a stranger shot her seven times at close range. Miraculously, hospital records show, none of the bullets damaged her internal organs. But after surgery, Bates said, she couldn’t get out of bed or walk to the bathroom without help. She complained of intense pain radiating down her left leg, weakness in her knee, and a numbing sensation below it, according to hospital records. Bates, who worked as an Uber Eats driver, didn’t have the strength to drive a car. Still, Bates said, the hospital told her it was time to go. (Chang, Clasen-Kelly and Pierce, 6/29)
The Battle over Flavor: FDA Wins This Round! By Esther Petrikovsky & Andrew J. Hull —
The Battle over Flavor: FDA Wins This Round!
By Esther Petrikovsky & Andrew J. Hull —
On June 24, 2026, the Fifth Circuit denied a petition brought by VDX Distro (VDX), an e-cigarette company, asking the court to review FDA’s decision to reject marketing authorization for its e-cigarette products. See VDX Distro, Inc. v. FDA, No. 24-60537 (5th Cir. 2026).
By way of background, e-cigarettes, considered a healthier alternative to combustible cigarettes, have been very popular among the younger generations, including children as young as middle schoolers. This phenomenon has been largely attributed to the various child-friendly flavors in which they have been made available. A 2024 survey found that a whopping 87.6% of middle and high schoolers who vape opted for a non-tobacco-flavored products, with “fruit” leading the polls and “candy” a not-so-close second.
https://www.thefdalawblog.com/2026/06/the-battle-over-flavor-fda-wins-this-round/?utm_source=rss&utm_medium=rss&utm_campaign=the-battle-over-flavor-fda-wins-this-round
domingo, 28 de junio de 2026
Fake Cancer Medicines Have Reached US Clinics And Most Providers Don’t Know It Jean Christophe Rusatira,Jean Berchmans Uwimana,Saifuddin Ahmed,andHenry J. Michtalik June 24, 2026
https://www.healthaffairs.org/content/forefront/don-t-fake-cancer-medicines-have-reached-us-clinics-and-most-providers-know?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-8sEzAnVLLsXTAyoKZpmIIMHO5sllD3A6mLVfYUzgl8pBeASnObPtIqCGRBnVjEiZFQm7JUayOmNKOXuK8dq5uG2ARmFA&_hsmi=425789085&utm_source=hasu
Providers in high-income countries underestimate the domestic scale of falsified medicine.
How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation Jason Shafrin,Richard Xie,andLouis P. Garrison, Jr. June 24, 2026
https://www.healthaffairs.org/content/forefront/import-price-import-threshold-foreign-reference-pricing-embeds-valuations-and-risks?utm_campaign=34032557-Health%20Affairs%20Sunday%20Update%202026&utm_medium=email&_hsenc=p2ANqtz-_issIK9IBjfLeM6_erjx6IbEK5fbSJmXCXKsFMObZ58Dl1h5EM4wupXdxbqDgKUInyxMHWjSlgt8I7oyaS6nSRtxTXCg&_hsmi=425789085&utm_content=425789085&utm_source=hs_email
Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more sustainable approach would be to define and apply US-specific measures of value and to invest in generating evidence around value.
Massively Better, By What Measure? Soleil Shah June 26, 2026
https://www.healthaffairs.org/content/forefront/massively-better-measure?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-8aGg1je1tRQMuR30qg-PzP8_DYJvaaQQFVOzkQw3ITv5ikL_8m_Lg6K0-IuZFypvV1ze5TZpYBnwDGXN92LWDZVY_WSw&_hsmi=425789085&utm_source=hasu
Perhaps the term “better” should not be defined by business metrics at all—but instead by the innovation’s health impacts among patients.
California Should Ensure That Medi-Cal Makes Mifepristone Accessible Angelina Wei June 25, 2026
https://www.healthaffairs.org/content/forefront/california-should-ensure-medi-cal-makes-mifepristone-accessible?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-92lNdA5AwdprUAVsYrAHaIqlo1FYw-VnlsS3D6EAO210Yzr7ps8Iot4T1iS6x2xUEITlML8Bxc5LvrZp3IxJVr8hXmQQ&_hsmi=425789085&utm_source=hasu
California cannot control whether mifepristone will remain available at the national level. But it can control whether Medi-Cal managed care plans can connect patients to providers and verified dispensing pathways in a timely manner.
How Ownership-Based ‘Food Is Medicine’ Initiatives Can Advance Structural Change Olivia Thomas,Ismail Samad,Norma Gonzalez,Kevin Nguyen,andMegan Sandel June 26, 2026
https://www.healthaffairs.org/content/forefront/drains-fountains-ownership-based-food-medicine-initiatives-can-advance-structural?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_GHBLlPoDCmWKIs_XGHzK8QgwCwueF9tTqsh3mLJWiLa-6Yqhh8W7-L3uu7CzLABSDm-u_ixlZKa22qPKVwZtKCh1usw&_hsmi=425789085&utm_source=hasu
In its current configuration, Food Is Medicine operates as a drain, not a fountain. Money flows into communities to pay for food and services, and grants are paid to support short-term projects, but the money invested does not stay there.
Making Naloxone Affordable For Communities Scott G. Weiner,Dima Qato,andJeremy Samuel Faust June 22, 2026
https://www.healthaffairs.org/content/forefront/making-naloxone-affordable-communities?utm_campaign=34032557-Health%20Affairs%20Sunday%20Update%202026&utm_medium=email&_hsenc=p2ANqtz-9xCCCxeVJFm6z3e2uNiVH0XhDQAbBo8zXo8BakSheQS60qqULrH9xnmfih0mU2IQ_GnSFzZ4JQ3xR2ECIXc0D3zmwXMA&_hsmi=425789085&utm_content=425789085&utm_source=hs_email
Nasal naloxone remains expensive relative to the cost of the underlying drug and continues to strain budgets of public health agencies that provide this life-saving treatment.
The Medical Community’s Obligation When Politics Undermine Evidence Standards Arjee Javellana Restar,Kristi Gamarel,Don Operario,Trace Kershaw,Meredithe McNamara,andKellan Baker June 22, 2026
https://www.healthaffairs.org/content/forefront/medical-community-s-obligation-politics-undermine-evidence-standards?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9o2029Y_yv6ZJFbB_L2vy0gcPB3ZzrHMbfg3b40whG9LdmnT9s7WPhd8Q7C8B-SUGOZnd0YrDVaGAzTb6pcVvz9Kb1vA&_hsmi=425789085&utm_source=hasu
If an HHS Secretary can seek to unilaterally overturn an evidence-based standard of transgender health care, the same can occur in any contested medical field. When medical necessity is politicized, the medical and public health communities must act.
America’s Infrastructure To Support Older Adults Is In Limbo Alison Barkoff June 25, 2026
https://www.healthaffairs.org/content/forefront/america-s-infrastructure-support-older-adults-limbo?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9i8BpUgQ3qjuwhCZ0Z2ev9wfZ-A1luOD_upkxgiWTOmg2YTVp3f8KTNtav_mMYZs0O6TJBRc8zKCMGjQyty0ZGoWM-DQ&_hsmi=425789085&utm_source=hasu
Amidst uncertainties around Older Americans Act reauthorization and turmoil at the Administration for Community Living, the nation’s aging network and advocates are trying to sustain the infrastructure that older adults need and deserve.
Making Medicaid Payment Policy Work For Patients, Providers, And Taxpayers Anne O’Hagen KarlandAvi Herring June 23, 2026
https://www.healthaffairs.org/content/forefront/making-medicaid-payment-policy-work-patients-providers-and-taxpayers?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_FWT_KyR9hl3slFFjNoWRLk0Abrcon0NgBHGSVh2gjLii5R01OLPBlTcH6CUxsmLR-kc70p8ASwh417d99YnLgMEahDA&_hsmi=425789085&utm_source=hasu
Rather than impose one-size-fits-all solutions, federal and state policy makers should craft Medicaid payment policies that target specific access or quality goals, and track whether those goals are being met.
Trump Administration Escalates Attacks On Transgender Health Care Using Subpoena Authority Ellie DeGarmoandKatie Keith June 18, 2026
https://www.healthaffairs.org/content/forefront/trump-administration-escalates-attacks-transgender-health-care-using-subpoena-authority?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-8oXMiN40jo-DFJtXMhfzckDKwV88omVedSOskBH_TwA7NDDSNDYjZwwVRZQH0cfYqNjRP04NjUMsJAvE_nOVNU5qfdyg&_hsmi=425789085&utm_source=hasu
Having been stymied by courts elsewhere, the Justice Department has turned to a conservative federal district court in Texas to enforce civil subpoenas and obtain criminal subpoenas—against non-Texas-based providers.
Administration Releases Medicare Drug Price Negotiation Program Proposed Rule For 2029 Kristi MartinandRachel Sachs June 24, 2026
https://www.healthaffairs.org/content/forefront/administration-releases-medicare-drug-price-negotiation-program-proposed-rule-2029?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-95haiixX_mZTy3ECO_NBLWn3niD5JFLvTzMsfIAWE-28DVKmHFRann8yByZ1G8xlLLiLoIhJMXYDem1Ycg_7s3sxgiuw&_hsmi=425789085&utm_source=hasu
The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of the Medicare Drug Price Negotiation Program.
Proposed Rule Would Curtail Medicaid State Directed Payments Arielle Kane June 26, 2026
https://www.healthaffairs.org/content/forefront/proposed-rule-would-curtail-medicaid-state-directed-payments?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9H4GZV_f_OEaE-a39eTqyQl0-P9hlbveEsBljF3onhoJlfmdrX-rbd-QPavkytbBWXD6p18lLlQdFFEZ5stBf2gXqMsA&_hsmi=425789085&utm_source=hasu
CMS is proposing to expand limits on state directed payments beyond what Congress specified in HR 1.
The NHE Projections Through 2034: Growth Assumptions, Policy Consequences Richard G. FrankandSherry Glied June 24, 2026
https://www.healthaffairs.org/content/forefront/nhe-projections-through-2034-growth-assumptions-policy-consequences?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_yzAUWwwSd2V8Mwlng9QB_wFpIXBdHVu8pHpw7a_GMWnG3YBqeA8Cv984p40kY61U1-z0Ke7ZYutIVFSLPr8iDqCRFDA&_hsmi=425789085&utm_source=hasu
The CMS actuaries are—understandably and reasonably—cautious. But recent developments indicate that changes in technology and policy may alter health care delivery and spending—and consequently our policy choices—in ways we are just beginning to imagine.
National Health Expenditure Projections, 2025–34: Strong Utilization Growth Initially, Legislative Impacts Later Authors: Jacqueline A. Fiore jacqueline.fiore@cms.hhs.gov, Andrea M. Sisko, John A. Poisal, Sheila D. Smith, Gigi A. Cuckler, Andrew J. Madison, Sean P. Keehan, Kathryn E. Rennie, and Nicholas J. Feehley
https://www.healthaffairs.org/doi/10.1377/hlthaff.2026.00642?utm_campaign=july+2026+issue&utm_medium=email&_hsenc=p2ANqtz--YdEjqBEyzYy6KnB6NyRXwiwQoRss4N7h0eaaukgurdy02RqNQhGUP2gOOJ_21b7n2eFN9R2TKtElvgTOx8nSY8JJehg&_hsmi=425789085&utm_content=ahead+of+print&utm_source=hasu
By 2034, national health spending is projected to total nearly $9.0 trillion and to represent 20.6 percent of the economy, compared with $5.3 trillion and 18.0 percent in 2024. The rate of national health spending growth during this period is influenced by continued elevated use of medical services and goods through 2026; major legislative changes that affect insurance coverage and spending through 2028; and continued demographic shifts toward public programs, mainly Medicare. The insured share of the population is expected to be 90.5 percent in 2034, compared with 91.8 percent in 2024.
sábado, 27 de junio de 2026
A Look at the High Unemployment Hardship Exception to Medicaid Work Requirements Based on Unemployment Data from February 2025 to January 2026 Authors: Clea Bell, Jennifer Tolbert, and Rhiannon Euhus Published: May 18, 2026
https://www.kff.org/medicaid/a-look-at-the-high-unemployment-hardship-exception-to-medicaid-work-requirements-based-on-unemployment-data-from-february-2025-to-january-2026/
The 2025 reconciliation law will—for the first time—require adults who are enrolled in Medicaid though the Affordable Care Act (ACA) expansion, along with those in partial expansion waiver programs in Georgia and Wisconsin, to meet work requirements or qualify for an exemption as a condition of eligibility starting in January 2027 in most states.
Federal Medicaid Spending Through State Directed Payments Nears $100 Billion Annually Across 41 States, With New Limits Set to Reduce Funding to States KFF analysis shows hospitals have the most spending through state directed payments Published: Jun 15, 2026
https://www.kff.org/medicaid/federal-medicaid-spending-through-state-directed-payments-nears-100-billion-annually-across-41-states-with-new-limits-set-to-reduce-funding-to-states/
Forty states and DC currently receive $93 billion in annual federal Medicaid spending through state directed payments (SDPs) and may be at risk due to forthcoming limits on these payments, according to new KFF estimates. Annual federal spending on SDPs is highest in California (an estimated $10.6 billion)—followed by Texas ($6.3 billion), North Carolina ($5.2 billion), and Illinois ($5.1 billion).
The Role of Immigrants in the U.S. Health Care Workforce Authors: Drishti Pillai and Samantha Artiga Published: Jun 18, 2026
https://www.kff.org/immigrant-health/the-role-of-immigrants-in-the-u-s-health-care-workforce/
The Trump administration has made policy changes to restrict immigration into the U.S., including efforts to end Temporary Protected Status (TPS) designations for many countries, pauses and restrictions on the issuance of new visas, and significantly increased immigration enforcement. These actions could have negative implications for the U.S. workforce, which includes significant shares of immigrant workers, particularly in certain industries including health care. Immigrant workers include naturalized citizens as well as noncitizens, including lawfully present and undocumented immigrants.
In 30 of the States Implementing Medicaid Work Requirements, Governors Are on the Ballot in November Published: June 22, 2026
https://www.kff.org/quick-insights/in-30-of-the-states-implementing-medicaid-work-requirements-governors-are-on-the-ballot-in-november/
A majority of states subject to new Medicaid work requirements — 30 of 44 — will hold gubernatorial elections this November, and leadership transitions, particularly those involving a change in party, could complicate state implementation of work requirements.
Is AI (Still) Biased? June 23, 2026
https://www.kff.org/other-health/is-ai-still-biased/
Episode 9, AI Series: In this episode, Dr. Ziad Obermeyer joins Chip to talk about AI bias in patient management, including how far the health care industry has come since his groundbreaking research that revealed alarming biases in a widely used algorithm that underestimated the health needs of Black patients. The discussion emphasizes that while AI can analyze data with remarkable precision, it is the context surrounding that data that ultimately determines its efficacy, usefulness, and fairness. Dr. Obermeyer is an emergency department physician, researcher, co-founder of Nightingale Open Science and Dandelion, and associate professor at the UC Berkeley School of Public Health and the College of Computing, Data Science, and Society.
The Medical Frailty Exemption from Medicaid Work Requirements: Key Takeaways from the CMS Interim Final Rule Authors: Amaya Diana, Jennifer Tolbert, and Robin Rudowitz Published: Jun 23, 2026
https://www.kff.org/medicaid/the-medical-frailty-exemption-from-medicaid-work-requirements-key-takeaways-from-the-cms-interim-final-rule/
On June 1, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a long-anticipated interim final rule that will guide state implementation of Medicaid work requirements. The 2025 reconciliation law requires 44 states to condition Medicaid eligibility for adults in the Affordable Care Act (ACA) Medicaid expansion group and enrollees in certain waiver programs, including in non-expansion states (Georgia, Tennessee, and Wisconsin), on meeting work requirements starting January 1, 2027, or sooner at state option. The law specifies mandatory exemptions, including individuals who are “medically frail.” Given the abbreviated implementation timeline, states had tentatively moved forward with key decisions over how to implement the medical frailty exemption even as they waited for formal guidance from CMS.
U.S. Global Health Legislation Tracker Published: Jun 23, 2026
https://www.kff.org/global-health-policy/u-s-global-health-legislation-tracker/
This tracker provides a listing of global health-related legislation being considered by the 119th Congress (Jan. 3, 2025 – Jan. 3, 2027). Currently, there are more than 50 pieces of legislation related to global health. They address topics ranging from global health security to reproductive health to the World Health Organization (WHO). Sometimes a bill may address broader topics, but this tracker focuses on the global health aspects of the legislation.
Medicaid Program Integrity: Tracking State-Specific and Nationwide Federal Action Published: Jun 25, 2026
https://www.kff.org/medicaid/medicaid-program-integrity-tracking-state-specific-and-nationwide-federal-action/
The Trump Administration and Congress continue to focus on rooting out fraud, waste, and abuse in federal programs, including Medicaid. Those efforts include 50-state initiatives and targeted actions that focus on issues in specific states. Given the quickly evolving Medicaid program integrity landscape, this page tracks emerging developments in the federal government’s approach to program integrity in Medicaid, along with the implications of those actions for different states. For more detailed analyses and context, see ‘Related Resources’ in Section 2.
KFF Poll Shows Three in Ten Adults Turn to Social Media or AI for Health Information, with Lower-Income Adults More Likely to Cite Cost and Access Barriers as a Reason Joel Luther , Hagere Yilma , and Irving Washington
https://www.kff.org/health-information-trust/kff-poll-shows-three-in-ten-adults-turn-to-social-media-or-ai-for-health-information-with-lower-income-adults-more-likely-to-cite-cost-and-access-barriers-as-a-reason/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-9q6gvGeNW2fsUJsr-Wv8RKdnsW8pt5XNa_AW99Dz_Jil0zQUquGIGs46gQdkZheXMjGT-lOFfV0MC1dHuES8F1jo_94g&_hsmi=425741639&utm_content=425741639&utm_source=hs_email
The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences or a desire for quick information. But nearly one in five say they turned to social media due to difficulties accessing or affording care, similar to the shares who cited access and cost as reasons for turning to AI for health information in a previous KFF poll.
These findings as well as data from dozens of past KFF polls can also be found on KFF’s Health Information and Trust Polling Dashboard.
Untold KFF History Volume 1: South Africa Author: Drew Altman Published: Jun 25, 2026
https://www.kff.org/from-drew-altman/untold-kff-history-volume-1-south-africa/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-9KKfOHHtc9w7SkqLmIj8s9LzM0SeoWg3iAwMZnrnp13zz-vOxQIpAgdx4ipivpshfAfAJSzkoiuJo1WDtcuL-eMixDdA&_hsmi=425741639&utm_content=425741639&utm_source=hs_email
As KFF approaches a leadership transition next year, Founding President and CEO Dr. Drew Altman will share a series of occasional columns about key moments in the organization’s 37-year history. The first in the series recalls KFF’s decades-long commitment to South Africa during and after apartheid. Dr. Altman will continue his regular columns about health policy. “The greatest privilege of my life was to be able to work with Nelson Mandela, and I sometimes wonder what he would make of today’s state of affairs here and in South Africa,” he writes.
viernes, 26 de junio de 2026
47 Senate Lawmakers Oppose VA Disability Rule on Sleep Apnea, Tinnitus The concerns espoused follow similar worries made evident by over a dozen military-related groups earlier this week.
47 Senate Lawmakers Oppose VA Disability Rule on Sleep Apnea, Tinnitus
The concerns espoused follow similar worries made evident by over a dozen military-related groups earlier this week.
https://www.military.com/47-lawmakers-oppose-va-disability-rule-on-sleep-apnea-tinnitus?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8_0vIZ628wOcR-jQ6GFXP7QaTAB2POzf3qUBUEH_INZxgKcLcktiMcl_JtvwLOujB5lLLT0j2MqdWtk3XgU0RzrxuEWQ&_hsmi=425699336&utm_content=425699336&utm_source=hs_email
Military.com: 47 Senate Lawmakers Oppose VA Disability Rule On Sleep Apnea, Tinnitus
Nearly 50 lawmakers in Congress are urging reconsideration of a Department of Veterans Affairs (VA) draft rule in a major proposed legislative package that they claim will negatively impact disabled veterans who suffer from sleep apnea and tinnitus. The rule, entitled "Schedule for Rating Disabilities—Ear, Nose, Throat, and Audiology Disabilities; Special Provisions Regarding Evaluation of Respiratory Conditions; Respiratory System," is currently contained within the comprehensive bill package called the Take Care of America's Veterans Act (TCAVA) that was introduced last week and includes more than 60 veterans' bills, such as the Major Richard Star Act, the Love Lives On Act, caregiver reforms, VA modernization initiatives, combat-injured veteran expansions, more support for military spouses and more. (Mordowanec, 6/25)
Trump administration plans to deport more than 500 migrant children within days, senator warns by Nathaniel Weixel -
Trump administration plans to deport more than 500 migrant children within days, senator warns
by Nathaniel Weixel -
https://thehill.com/policy/healthcare/5941396-wyden-warns-trump-deportations-migrant-children/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--GsC0Xk9mHItmgNZiZpqcSI_Tk6DN2WktazR1hVHWOXVc-9BIyPLOGXBp9MGD_qqp4SUuA3j-Pm2WWIftHth14Ej9kuw&_hsmi=425699336&utm_content=425699336&utm_source=hs_email
The Hill: Trump Plans Deportation Of 500 Migrant Children: Sen. Ron Wyden
The Trump administration is planning to bypass legal protections and hastily deport more than 500 unaccompanied migrant children, a top Democratic senator warned Thursday. Sen. Ron Wyden (D-Ore.) told Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. in a letter that he “obtained credible information” that the Trump administration had a list of more than 500 migrant children currently in the care and custody of the agency’s Office of Refugee Resettlement (ORR) who were being targeted for fast-track removal in a matter of days. The children have been in ORR custody, primarily in long-term foster care, for at least six months and do not have any relative or guardian in the U.S. to act as a sponsor. (Weixel, 6/25)
‘The decision is sickening’: MAHA leaders feel betrayed by Supreme Court ruling on Roundup weed killer
‘The decision is sickening’: MAHA leaders feel betrayed by Supreme Court ruling on Roundup weed killer
The Trump administration backed Bayer, the maker of Roundup, angering prominent voices in the “Make America Healthy Again” movement.
https://www.nbcnews.com/health/health-news/supreme-court-ruling-roundup-weedkiller-maha-betrayed-rcna351796?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--88DboYaARJEz4WfUzwnntp_WS5f0SgpdGrvYNZQjWmfB-krpoCMZBlVaXEmN_oMW35JRY6B5S55KG_D4Scv0bcg_SXg&_hsmi=425699336&utm_content=425699336&utm_source=hs_email
California Hospitals, Labor Union Broker Ballot Deal To Reshape Healthcare Funding
California Hospitals, Labor Union Broker Ballot Deal To Reshape Healthcare Funding
SEIU-United Healthcare Workers West, the state's largest union, and the California Hospital Association agreed to drop contentious proposals that would have appeared on the ballot come November, hours before a state deadline. A separate measure to impose a one-time tax on billionaires remains on the ballot and could reshape how California funds healthcare, CalMatters wrote.
https://kffhealthnews.org/morning-breakout/state-watch-062626/
Semaglutide Use Has Prompted 'Staggering' Number Of GLP-1 Poison Control Calls
Semaglutide Use Has Prompted 'Staggering' Number Of GLP-1 Poison Control Calls
According to a study, call volumes nearly doubled after the 2021 approval of semaglutide for the treatment of obesity, rising from roughly 1,000 to 1,500 cases annually to over 8,000 by 2023, HealthDay News reports.
https://kffhealthnews.org/morning-breakout/pharmaceuticals-062626/
Judge Blocks Loan Caps For Some Students Planning To Work In Health Sector
Judge Blocks Loan Caps For Some Students Planning To Work In Health Sector
Judge Beryl Howell of the U.S. District Court for the District of Columbia said trade groups and healthcare organizations “are likely to succeed on their [Administrative Procedure Act] claim that the Rule’s definition of ‘professional degree’ is contrary to law.” She also noted that blocking the rule is in the public interest. Plus: Modern Healthcare examines the physician assistant shortage.
https://kffhealthnews.org/morning-breakout/health-industry-062626/
New ACIP Charter Allows RFK Jr. To Keep Vaccine Critics He Put In Place
New ACIP Charter Allows RFK Jr. To Keep Vaccine Critics He Put In Place
Public health experts panned the revised charter — posted to the CDC's website this week — as a way for Health and Human Services Secretary Robert F. Kennedy Jr. to shape his anti-vaccine policy. Under his previously revised charter, a court ruled that ACIP's panelists lacked the qualifications to guide vaccine policy. Plus, a request by military branches to continue vaccinating trainees for the flu went unanswered until June 16, The New York Times reported.
https://kffhealthnews.org/morning-breakout/vaccines-062626/
Trump Sets In Motion Effort To Limit Pesticides In Nation's Food Supply
Trump Sets In Motion Effort To Limit Pesticides In Nation's Food Supply
The president has instructed his team to study pesticide use, "prioritize" the approvals of alternatives, and find "creative solutions for evaluating the exposure, diagnosis, and treatments of cumulative chemical exposures on individual health.” MAHA members derided the executive order, with one noting that “Americans ... deserve a clear plan with accountability to reduce unnecessary chemical exposures in our food supply.”
https://kffhealthnews.org/morning-breakout/administration-news-062626/
Hospitals, Hospices, Nursing Homes Brace For Loss Of Thousands Of Immigrant Workers After Supreme Court Ruling
Hospitals, Hospices, Nursing Homes Brace For Loss Of Thousands Of Immigrant Workers After Supreme Court Ruling
Healthcare leaders warned that elderly care would bear the brunt of the ruling, which lets the Trump administration end temporary protections for more than 350,000 people from Haiti and Syria. At least one Republican, Rep. Mike Lawler of New York, said the ruling "will create a crisis" in healthcare.
https://kffhealthnews.org/morning-breakout/hospitals-hospices-nursing-homes-brace-for-loss-of-thousands-of-immigrant-workers-after-supreme-court-ruling/
Notable Approval: FDA Approves First Treatment Shown to Reduce the Risk of Acute Pancreatitis in Adults with Severe Hypertriglyceridemia
https://content.govdelivery.com/accounts/USFDA/bulletins/41d837e
Notable Approval: FDA Approves First Treatment Shown to Reduce the Risk of Acute Pancreatitis in Adults with Severe Hypertriglyceridemia
The U.S. Food and Drug Administration (FDA) has approved Tryngolza (olezarsen), used with diet, to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia.
Tryngolza is injected subcutaneously (under the skin) once per month.
Condition
Severe hypertriglyceridemia is a serious condition, defined by fasting triglyceride levels of at least 500 mg/dL. Guidelines recommend lowering triglycerides when levels are higher than 500 mg/dL to reduce the risk of acute pancreatitis (sudden inflammation of the pancreas that can be serious or life-threatening). For reference, normal triglyceride levels are less than 150 mg/dL. Standard treatment for severe hypertriglyceridemia includes lifestyle and diet modifications (such as treatment of obesity and diabetes mellitus, regular exercise, limited to no alcohol consumption, and a low-fat diet) and medications. Medications previously approved by the FDA to lower triglycerides in patients with severe hypertriglyceridemia have not had enough cases of acute pancreatitis in their trials to be able to show a reduced risk of acute pancreatitis.
Data Supporting Tryngolza
The efficacy and safety of Tryngolza were demonstrated in two randomized, double-blind, placebo-controlled trials (NCT05079919 and NCT05552326) in a total of 1,061 adults with severe hypertriglyceridemia. Across these trials, the average baseline triglyceride level was 1,116 mg/dL. The primary endpoint for both trials was the percent change in fasting triglyceride levels from baseline to month 6 (average of triglyceride levels at weeks 25 and 27) compared to placebo.
In the first trial, the average percent change in triglycerides from baseline to month 6 in the Tryngolza treatment group was -63% for the 50 mg dose and -72% for the 80 mg dose compared to the placebo group. In the second trial, the average percent change in triglycerides from baseline to month 6 in the Tryngolza treatment group was -49% for the 50 mg dose and -55% for the 80 mg dose compared to the placebo group. In the integrated analysis of the two trials, the rate of acute pancreatitis was reduced in the pooled TRYNGOLZA group compared with placebo.
Safety Information
The most common adverse reactions in patients treated with Tryngolza for severe hypertriglyceridemia are injection site reactions and liver enzyme increases. Health care providers should consider liver enzyme testing before Tryngolza initiation or an increase in dosage and when indicated thereafter. If elevations in liver enzymes persist, health care providers may consider dose interruption (a pause in taking the medication) and/or dose reduction.
Potential allergic reactions including redness of the skin, hives (red itchy bumps), swelling of the face, chills or trouble breathing have been reported in patients treated with Tryngolza. Health care providers should inform patients about the signs and symptoms of allergic reactions and instruct patients to promptly seek medical attention and discontinue the use of Tryngolza if these occur.
Designation
Tryngolza received Priority Review and Breakthrough Therapy designations for this indication. The approval was granted to Ionis Pharmaceuticals.
Scars of conflict: trauma exposure, depression, and vulnerability in Kashmiri women Mehwish Imtiaz* [1] , Chahat Jamwal [1] , Athiya Fahiem Khan [1] , Mohammad Maqbool Dar [1]
https://www.academia.edu/2997-9196/3/2/10.20935/MHealthWellB8232
Introduction: In conflict-affected regions like Kashmir, women are frequently exposed to multiple traumatic events, increasing their risk for psychiatric disorders. Trauma is often underrecognized in clinical settings, limiting opportunities for gender-sensitive, trauma-informed interventions. This study aimed to: (1) quantify and characterize traumatic life events among women attending a tertiary mental health facility in Kashmir. (2) examine associations between cumulative trauma burden and psychiatric diagnoses, particularly major depressive disorder (MDD) and trauma-related disorders. (3) identify sociodemographic factors contributing to psychiatric vulnerability.
Materials and methods: In this cross-sectional study, 300 women aged ≥ 18 years attending a women’s mental health clinic were assessed. Diagnoses were established using the Mini International Neuropsychiatric Interview (M.I.N.I. 7.0.2, DSM-5). Cumulative trauma burden was measured with the Life Events Checklist for DSM-5 (LEC-5). Sociodemographic data were collected using a semi-structured proforma. Analyses included Chi-square tests, logistic regression, and cluster analysis.
Results: MDD (59.3%), bipolar disorder (11.7%), and trauma-related disorders (11%) were the most common diagnoses. Over one-third reported more than 11 traumatic events, most frequently natural disasters (95%) and war-zone exposure (66.6%). High cumulative trauma burden was strongly associated with MDD and trauma-related disorders. Older age, marital status, illiteracy, unemployment, and high trauma burden significantly predicted adverse psychiatric outcomes (p < 0.001). Cluster analysis identified two profiles: high trauma burden with depression, and lower trauma exposure with relatively stable outcomes.
Conclusions: Cumulative trauma burden and sociodemographic vulnerabilities substantially influence women’s mental health in conflict settings, underscoring the need for trauma-informed, gender-sensitive clinical assessments, interventions, and community-based mental health programs.
https://www.academia.edu/journals/academia-mental-health-and-well-being/articles?source=journal-top-nav
Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials June 2026
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/quantitative-systems-pharmacology-qsp-based-dose-selection-minimum-anticipated-biological-effect?utm_medium=email&utm_source=govdelivery
FDA Publishes Draft Guidance Entitled “Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials”
The U.S. Food and Drug Administration (FDA) recently published the draft guidance entitled "Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials."
Selecting an appropriate initial dose for FIH trials is a critical step. In the past decade, QSP has emerged as a modeling approach that can be used in regulatory submissions to evaluate complex drug-biological system interactions. By integrating biology and exposure-response understanding, QSP can inform FIH dose selection and dose escalation. The use of QSP modeling for this purpose also aligns with FDA’s broader strategy to reduce reliance on animal studies.
Report on the State of Pharmaceutical Quality
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/report-state-pharmaceutical-quality?utm_medium=email&utm_source=govdelivery
FDA is announcing the fiscal year 2025 Report on the State of Pharmaceutical Quality from the Office of Pharmaceutical Quality (OPQ). The mission of OPQ in FDA’s Center for Drug Evaluation and Research is to assure that quality medicines are available for the American public. In this report, OPQ analyzes FDA-registered drug manufacturers and their CDER-regulated drug products, including biologics, to inform stakeholders about the quality of the U.S. drug supply.
In addition to key data that characterize site quality and product quality, this report presents several deeper analyses:
During CY2020-CY2025, the distributions of manufacturing locations for U.S.-based application products trended away from the U.S. and Europe and toward China and India.
BLAs have increased from 2.3% of all approvals in FY2016 to 4.6% in FY2025 with biosimilars representing 42% of the approved BLAs in FY2025, up from 17% in FY2016.
In FY2025, 74% of the pre-approval §704(a)(4) record requests were sent to foreign pharmaceutical firms, with the highest number sent to India and China.
A study of benzene in OTC products found concentrations below 2 ppm and demonstrated that manufacturers can consistently meet lower limits.
A study of diethylene glycol (DEG) and ethylene glycol (EG) in OTC drug products provided assurance to U.S. consumers about the quality of the tested products.
A two-year review of original applications and supplements requiring facility assessments found that most facility withholds occurred at facilities with pre-existing Official Action Indicated (OAI)-related status.
We encourage the pharmaceutical industry and its stakeholders, including the public, to read this year’s report and collaborate with FDA to continuously improve the state of pharmaceutical quality.
Riders on the Storm Part 3: Devices, Compounding, GLP-1 Medications, and Food By Jennifer D. Newberger & Sara W. Koblitz & Deborah L. Livornese & Dara Katcher Levy & Mark A. Tobolowsky & Kalie E. Richardson & Riëtte van Laack & Mary Bass —
https://www.thefdalawblog.com/2026/06/riders-on-the-storm-part-3-devices-compounding-glp-1-medications-and-food/?utm_source=rss&utm_medium=rss&utm_campaign=riders-on-the-storm-part-3-devices-compounding-glp-1-medications-and-food
This third installment of our series analyzing the rider provisions in the fiscal year 2026 appropriations legislation continues our examination of key FDA policy directives embedded in congressional committee reports. This post focuses on provisions related to medical devices, pharmacy compounding, GLP-1 medications, and food-areas where Congress has expressed heightened interest in FDA enforcement, regulatory clarity, and patient safety. As with prior installments, these rider provisions, while non-binding, offer valuable insight into congressional priorities and potential areas of future regulatory focus for FDA-regulated industries.
Riders on the Storm Part 2: The Drug Provisions
June 25, 2026
By Jennifer D. Newberger & Sara W. Koblitz & Deborah L. Livornese & Dara Katcher Levy & Mark A. Tobolowsky & Kalie E. Richardson & Riëtte van Laack & Mary Bass —
This is the second in our series analyzing the riders attached to the FY 2026 Labor-HHS Appropriations Bill. This installment examines the drug-related provisions, which cover a wide range of topics from accelerated approval and rare disease therapies to biosimilars and opioid regulation. The Committee’s report reflects ongoing congressional priorities while also addressing persistent industry frustrations and emerging regulatory challenges. Below, we summarize the key drug-related provisions and offer our analysis of what they may mean for sponsors, manufacturers, and the broader pharmaceutical landscape.
https://www.thefdalawblog.com/2026/06/riders-on-the-storm-part-2-the-drug-provisions/
Riders on the Storm Part 1: What the FY2027 Appropriations Report Means for FDA
June 24, 2026
By Jennifer D. Newberger & Sara W. Koblitz & Deborah L. Livornese & Dara Katcher Levy & Mark A. Tobolowsky & Kalie E. Richardson & Riëtte van Laack & Mary Bass —
On May 1, 2026, the House Committee on Appropriations submitted House Report 119-632 to accompany H.R. 8646—the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2027, which passed on June 4, 2026. The report serves as the Committee’s explanation of the accompanying bill, setting forth funding levels, programmatic directives, and policy priorities across the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), the Commodity Futures Trading Commission (CFTC), and the Farm Credit Administration (FCA). Given that of these acronyms our blog has only FDA in the title, it should come as no surprise that we are focused only on the FDA provisions, of which there are plenty—so many that we needed to split the post into three parts. The first, published today, will cover a few key provisions from the Act and the cross-product riders. Post 2 will look at the drug-specific provisions (including biosimilars). And Post 3 will look at everything else, including devices and compounding.
https://www.thefdalawblog.com/2026/06/riders-on-the-storm-part-1-what-the-fy2027-appropriations-report-means-for-fda/
jueves, 25 de junio de 2026
Research Roundup: The Latest Science, Discoveries, And Breakthroughs ++
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Each week, KFF Health News compiles a selection of health policy studies and briefs.
https://kffhealthnews.org/morning-breakout/health-policy-research-050726/
Viewpoints: Stop Tiptoeing Around It — The US Has Already Lost Its Measles Status; Despite Fearmongering, Sunscreen Is Safe
https://kffhealthnews.org/morning-breakout/viewpoints-has-us-already-lost-measles-elimination-status-despite-fearmongering-sunscreen-is-safe/
Trump Admin Requests $1.4B For Ebola Quarantine Unit, Health Security Funds, Diplomatic Efforts
Trump Admin Requests $1.4B For Ebola Quarantine Unit, Health Security Funds, Diplomatic Efforts
As the Ebola crisis widens, scientists are set to test two drugs — Gilead Sciences’ antiviral drug remdesivir and MappBio’s monoclonal antibody MBP-134 — to determine whether either is an effective treatment against the disease. The clinical trials will take place in Congo.
https://kffhealthnews.org/morning-breakout/outbreaks-and-health-threats-062526/
Amid Nationwide Shortage Of Chemo Drugs, Some Cancer Patients Are Being Prioritized For Treatment
Amid Nationwide Shortage Of Chemo Drugs, Some Cancer Patients Are Being Prioritized For Treatment
The New York Times reports the shortages were brought on by manufacturing difficulties, shipping delays, and decisions by some companies to stop producing the medications altogether, according to the FDA.
https://kffhealthnews.org/morning-breakout/pharma-and-tech-062526/
HHS Cuts Funding For Grants To Prevent Teen Pregnancies
HHS Cuts Funding For Grants To Prevent Teen Pregnancies
The Trump administration has paused or rescinded grants and contracts it says do not align with the president’s priorities, Bloomberg reported. One expert opposed to the changes said, “To attempt to remake it into a funding stream for conservative ideology ... denies young people the high-quality sexual health education they need and deserve."
https://kffhealthnews.org/morning-breakout/reproductive-health-062526/
Forest Service Will Allow Federal Firefighters To Wear N95 Respirators
Forest Service Will Allow Federal Firefighters To Wear N95 Respirators
One firefighter called it "long, long overdue." The Forest Service has been slow to address the serious health effects of smoke and to enact worker protections, NBC News wrote. Other administration news is on the affordable-housing bill; transgender medical records; deaths at national parks; the worsening flu outbreak at Lackland Air Force Base; and more.
https://kffhealthnews.org/morning-breakout/administration-news-062526/
Health Spending Set To Outpace Economic Growth, Reach $9 Trillion By 2034, CMS Estimates
Health Spending Set To Outpace Economic Growth, Reach $9 Trillion By 2034, CMS Estimates
The Centers for Medicare & Medicaid Services Office of the Actuary also expects the U.S. uninsured rate to rise from 8.2% to 9.5% by 2034. Modern Healthcare breaks down the projections.
https://kffhealthnews.org/morning-breakout/healthcare-costs-062526/
Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees By Julie Appleby June 25, 2026
Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
Some Senate Democrats want to cap the amount beneficiaries in traditional Medicare have to pay toward care, but the move is expected to draw GOP opposition for potentially adding billions to Medicare costs.
By Julie Appleby
June 25, 2026
https://kffhealthnews.org/medicare/medicare-costs-out-of-pocket-cap-democrats-senate-wyden-midterms/
Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US By Rae Ellen Bichell, Claire Galofaro, The Associated Press, Maia Rosenfeld, Renuka Rayasam, Aaron Kessler, The Associated Press, and Byron Tau, The Associated Press June 2, 2026
Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US
By Rae Ellen Bichell, Claire Galofaro, The Associated Press, Maia Rosenfeld, Renuka Rayasam, Aaron Kessler, The Associated Press, and Byron Tau, The Associated Press June 2, 2026
https://kffhealthnews.org/courts/ice-immigration-detention-medical-care-neglect-court-records-ap-investigation/?utm_campaign=KHN%3A%20Colorado&utm_medium=email&_hsenc=p2ANqtz--7OaZapn4oqSioPMFj4KmqSlM4DK4opD4qXY8_kqvFAnZ4wFn1w4S1p6aUBlsUP-bqaKhfEQHDHlWi2E-ZeWO_21wt4A&_hsmi=425357510&utm_content=425357510&utm_source=hs_email
By Rae Ellen Bichell, Maia Rosenfeld, and Renuka Rayasam, KFF Health News; Claire Galofaro, Aaron Kessler, and Byron Tau, The Associated Press
An Albanian man’s pain grew so unbearable, he said, he pulled out his own tooth as he languished for months in a New Mexico immigration detention center. A Honduran mother of two said she was hospitalized for a heart problem after she was denied blood pressure medications while held in Florida. A Venezuelan man said his leg grew purple and swollen from flesh-eating bacteria when staffers at a Vermont facility did not bring him to a scheduled doctor appointment.
Hundreds of detainees across at least 33 states allege in federal suits that immigration detention facilities are failing to provide adequate medical care, an investigation by KFF Health News and The Associated Press found. Detainees say they didn’t get medications on time — or at all — for conditions including high blood pressure, diabetes, depression, epilepsy, Parkinson’s, and HIV. Requests for help went unanswered for weeks. Blood sugars rose. Infections festered. Cancers remained untreated. Detainees collapsed and had seizures.
Detainees are frequently moved across the country, often without warning, interrupting treatment. A woman from El Salvador said she missed a week of HIV medication when she was transferred from Colorado to a county jail in Wyoming.
KFF Health News and AP analyzed thousands of court cases filed since Trump’s second inauguration that use a legal route known as habeas corpus to argue people are being held illegally by ICE. The records offer a rare window into how those detained say, often under penalty of perjury, ICE is handling their medical needs. Reporters also interviewed more than 50 detainees, family members, and lawyers.
Science Literacy Project Daily Digest +++ +++ +
Science Literacy Project Daily Digest
Science Controversies in the Media
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Sarah Kaplan | Washington Post
https://geneticliteracyproject.org/2026/06/25/viewpoint-trumps-reflecting-pool-algae-fiasco-points-to-a-bigger-culprit-climate-change/
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits
Jade Cobern, Luis Martinez, Mary Kekatos, Steve Beynon | ABC News
https://geneticliteracyproject.org/2026/06/25/hegseth-reversal-as-air-force-flu-outbreak-continues-to-surge-military-reinstitutes-mandatory-vaccines-for-recruits/
Desperate patients of autistic children paying up to $20,000 for bogus stem cell injections recommended by RFK, Jr.
Ed Pilkington | The Guardian
https://geneticliteracyproject.org/2026/06/25/desperate-patients-of-autistic-children-paying-up-to-20000-for-bogus-stem-cell-injections-recommended-by-rfk-jr/
After Mel Gibson’s Joe Rogan comments, grifters promoting ivermectin, without evidence, as a hantavirus preventive
Marisha Goldhamer | FactCheck
https://geneticliteracyproject.org/2026/06/25/after-mel-gibsons-joe-rogan-comments-grifters-promoting-ivermectin-without-evidence-as-a-hantavirus-preventive/
AI’s promotion of ‘fake news’ erodes everyday thinking, MIT study reveals
Jude Cramer | Fast Company
https://geneticliteracyproject.org/2026/06/24/ais-promotion-of-fake-news-erodes-everyday-thinking-mit-study-reveals/
Viewpoint: RFK, Jr. ignores oversight of vast HHS programs to focus on his pet obsessions—and gets much of the science wrong
Sheryl Gay Stolberg | New York Times
https://geneticliteracyproject.org/2026/06/24/viewpoint-rfk-jr-ignores-oversight-of-vast-hhs-programs-to-focus-on-his-pet-obsessions-and-gets-much-of-the-science-wrong/
Trump and climate change skeptics misrepresent updated climate-emissions scenarios to claim projections were bogus
Kate Yandell | FactCheck
https://geneticliteracyproject.org/2026/06/24/trump-and-climate-change-skeptics-misrepresent-updated-climate-emissions-scenarios-to-claim-projections-were-bogus/
Anti-vaxxers falsely claim chronic disease study of 22 diseases ‘proves’ that vaccinated children are sicker than the unvaccinated
Ed Payne | Lead Stories
https://geneticliteracyproject.org/2026/06/24/anti-vaxxers-falsely-claim-chronic-disease-study-of-22-diseases-proves-that-vaccinated-children-are-sicker-than-the-unvaccinated/
UK Physicians & Relationships Report 2026 Peter Russell
https://www.medscape.com/p11/uk-physicians-relationships-report-2026-2026a1000fpd
How do doctors in the UK manage romantic relationships alongside medical work?
Medscape surveyed 896 practising UK physicians between October 22, 2025, and March 3, 2026. Findings were unweighted and based on a random sampling of Medscape members, so they were not necessarily projectable to a wider population.
Do Involuntary Admissions Affect Clinicians’ Mental Health? Nekane Lauzirika
https://www.medscape.com/viewarticle/do-involuntary-admissions-affect-clinicians-mental-health-2026a1000ln0
When emergency clinicians initiate involuntary psychiatric admissions, the consequences may extend beyond the immediate crisis. A Spanish study explored how these interventions affect both patients and healthcare professionals.
Out-of-hospital emergency medical professionals frequently encounter situations in which involuntary admission to a healthcare facility is necessary. In these exceptional circumstances and in accordance with current healthcare legislation, coercive measures may be required when an individual lacks the capacity to provide informed consent or poses a risk to themselves or others. Researchers are calling for greater psychological support and training of the clinicians involved in these interventions.
Primary Care Meets Artificial Intelligence Lambeth Hochwald June 25, 2026
https://www.medscape.com/viewarticle/primary-care-meets-artificial-intelligence-2026a1000lk8
Within the next few years, patients will go to their primary care facility for a medical problem. They’ll be greeted by a nonhuman who speaks in the language of their choice. Based upon the initial interview, which will be taken in note form, the patient will be diagnosed, and a prescription called into the pharmacy. They’ll pay the robot at a reception kiosk and their meds will be delivered via driver-less car.
miércoles, 24 de junio de 2026
Drug Trials Snapshots
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots?utm_medium=email&utm_source=govdelivery
The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has released the 2025 Drug Trials Snapshots (DTS) Summary Report.
The report summarizes CDER’s 2025 DTS program, which captures the demographic groups represented in the clinical trials that supported the 46 novel drug approvals in 2025. Overall, approximately 26,000 patients participated in these trials. The summary provides a percent participation of demographic groups by sex, race, ethnicity, age group, and U.S. participation for each of the approved novel drugs.
CDER created the DTS transparency initiative in 2015 to report on the representation of participants in clinical trials and, to the extent possible, to summarize the safety and effectiveness data by sex, age, race, and ethnicity. For more information about the DTS program, please contact Snapshots@fda.hhs.gov.
Cambridge researchers discover three distinct severe pneumonia biological subtypes
https://www.news-medical.net/news/20260623/Cambridge-researchers-discover-three-distinct-severe-pneumonia-biological-subtypes.aspx
Cambridge researchers have shown that severe pneumonia has three different subtypes, helping explain why some patients in intensive care units (ICUs) recover from their illness faster than others, while for other patients the disease can be life-threatening.
Family court care proceedings increase mortality risk among first-time mothers
https://www.news-medical.net/news/20260623/Family-court-care-proceedings-increase-mortality-risk-among-first-time-mothers.aspx
First-time mothers whose children go through family court care proceedings in England are 21 times more likely to die within 10 years of having their baby compared with other mothers, a new study by UCL researchers finds.
Human-AI teams improve healthcare only when clinicians stay in control
https://www.news-medical.net/news/20260624/Human-AI-teams-improve-healthcare-only-when-clinicians-stay-in-control.aspx
A major review finds that AI can help clinicians work faster and more accurately, but only when systems are built around real clinical workflows, calibrated trust, and clear accountability.
A new scoping review available as an article in press in the journal npj Digital Medicine discusses recent evidence on the utility of human-artificial intelligence (AI) collaboration in healthcare.
Hidden costs push United States dementia toll to historic high
https://www.news-medical.net/news/20260624/Hidden-costs-push-United-States-dementia-toll-to-historic-high.aspx
A new USC-led study finds Alzheimer's disease and related dementias will cost the United States an estimated $818 billion this year, driven largely by often-overlooked costs to persons living with dementia and family and friends providing their care.
Judge rules government can’t stop SNAP dollars from buying candy and sugary drinks Decision scuttles restrictions now in place or planned for federally funded, state-run SNAP in 23 states
https://www.statnews.com/2026/06/23/snap-dollars-buying-candy-sugary-drinks-judge-ruling/
By Associated PressJune 23, 2026
Want high-quality generic drugs? One expert has ideas on how consumers can trust their supply Stanford’s Kevin Schulman argues FDA should encourage testing by independent, accredited labs
https://www.statnews.com/pharmalot/2026/06/23/high-quality-generic-drugs-lab-testing/
By Ed SilvermanJune 23, 2026
Pharmalot Columnist, Senior Writer
Ophthalmology venture grabs investors’ attention, raises $330 million Ollin Biosciences is developing treatments for eye diseases
https://www.statnews.com/2026/06/24/ophthalmology-biotech-ollin-biosciences/
By Allison DeAngelisJune 24, 2026
Biotech Startups and Venture Capital Reporter
New human embryo editing advances require tough conversations on ethical boundaries Given how quickly science is developing, we need a temporary moratorium on heritable human gene editing
https://www.statnews.com/2026/06/24/embryo-editing-dieter-egli-ethical-boundaries-moratorium/
By Paul KnoepflerJune 24, 2026
Knoepfler is a professor of cell biology and human anatomy at UC Davis School of Medicine.
What an abandoned heart failure trial says about ‘breakthrough’ devices that don’t reach patients Majority of devices in the FDA’s breakthrough program aren’t authorized. It’s rare to learn why
https://www.statnews.com/2026/06/24/fda-breakthrough-devices-what-we-learned-livanova-vitaria-results/
By Katie PalmerJune 24, 2026
Health Tech Correspondent
Riders on the Storm Part 1: What the FY2027 Appropriations Report Means for FDA By Jennifer D. Newberger & Sara W. Koblitz & Deborah L. Livornese & Dara Katcher Levy & Mark A. Tobolowsky & Kalie E. Richardson & Riëtte van Laack & Mary Bass —
https://www.thefdalawblog.com/2026/06/riders-on-the-storm-part-1-what-the-fy2027-appropriations-report-means-for-fda/?utm_source=rss&utm_medium=rss&utm_campaign=riders-on-the-storm-part-1-what-the-fy2027-appropriations-report-means-for-fda
On May 1, 2026, the House Committee on Appropriations submitted House Report 119-632 to accompany H.R. 8646—the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2027, which passed on June 4, 2026. The report serves as the Committee’s explanation of the accompanying bill, setting forth funding levels, programmatic directives, and policy priorities across the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), the Commodity Futures Trading Commission (CFTC), and the Farm Credit Administration (FCA). Given that of these acronyms our blog has only FDA in the title, it should come as no surprise that we are focused only on the FDA provisions, of which there are plenty—so many that we needed to split the post into three parts. The first, published today, will cover a few key provisions from the Act and the cross-product riders. Post 2 will look at the drug-specific provisions (including biosimilars). And Post 3 will look at everything else, including devices and compounding.
Suscribirse a:
Entradas (Atom)
.png)
